Heart rhythm registry for arrhythmogenic cardiomyopathy
Part of Genetic & congenital, Heart & circulation clinical trials.
This registry collects information from people with a specific heart condition called arrhythmogenic cardiomyopathy who have an ICD (a device that helps control heart rhythm). The goal is to learn more about heart rhythm problems and how the ICD responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with arrhythmogenic cardiomyopathy (a condition where heart muscle is replaced by fatty or scar tissue, affecting the heart's electrical signals).
- You have an ICD (a device implanted in your chest to monitor and correct dangerous heart rhythms).
- You have had at least one episode of a serious fast heart rhythm (sustained ventricular tachyarrhythmia) that was recorded.
- You are willing to attend regular check-ups where your ICD is monitored.
- Your medical records include clear tracings of your heart's electrical activity (ECG or EGM) that can be reviewed by the study doctors.
- You do not have significant narrowing of the heart arteries (more than 50% blockage), major valve or congenital heart disease, or heart muscle inflammation from conditions like sarcoidosis or amyloidosis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a cardiac rehabilitation program designed for people with a high genetic risk of arrhythmogenic cardiomyopathy (a condition that affects the heart's rhythm and structure). It aims to see if a safe, supervised exercise plan can help improve heart function and quality of life.
This trial is a real-world registry that collects information from people who receive an implantable heart defibrillator or related device. It helps doctors understand how these devices are used and how patients do over time.
This study is a “registry,” meaning it collects information about people undergoing a procedure to treat abnormal heart rhythms like ventricular tachycardia (VT) or premature ventricular contractions (PVCs). It may help researchers better understand which patients benefit from the procedure and how it is done over time.
This study observes people with atrial fibrillation or ventricular tachycardia who are having their first catheter ablation procedure. The goal is to collect information to improve future treatments.
This study is building a Canadian database and tissue/blood bank for people and families with inherited heart rhythm conditions (and some inherited heart muscle diseases). It collects consented health and genetic information to help researchers better understand who is at risk and how these conditions work.
This is a registry that collects information about people with certain dangerous heartbeat rhythm problems caused by structural (anatomical) heart diseases. It may help researchers understand patterns and risks, and improve how these conditions are studied and managed.
Hear when a new Arrhythmogenic Cardiomyopathy (AC, ARVD/C) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.